News related to Duoneb (Albuterol / Ipratropium) and/or conditions it is approved for
Chronic Obstructive Pulmonary Disease
Source: MedicineNet Alpha 1 Antitrypsin Deficiency Specialty [2006.10.13]
Title: Chronic Obstructive Pulmonary Disease
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 10/13/2006
Papworth Hospital Trial New 'Airway Bypass' For Emphysema Sufferers, England
Source: Respiratory / Asthma News From Medical News Today [2008.11.26]
Papworth Hospital NHS Foundation Trust is pleased to announce on World COPD Day (Chronic Obstructive Pulmonary Disease) its participation in a trial of a new treatment for severe emphysema. Papworth is one of 45 hospitals in the world and only 2 in the UK participating in a worldwide trial to evaluate the effectiveness of the airway bypass procedure to relieve breathlessness in patients with advanced widespread 'homogeneous' emphysema.
Royal Brompton Experts Train Commuters On Life-Saving Lung Health, England
Source: Respiratory / Asthma News From Medical News Today [2008.11.26]
Commuters travelling through London's busy Victoria train station were offered free health checks last Wednesday (19th November 2008) when some of the country's leading respiratory doctors from Royal Brompton Hospital were on hand to give expert advice. The event coincided with World COPD Day (chronic obstructive pulmonary disease) which aims to raise awareness and improve the care of lung disease across the globe.
Diesel Exhaust Linked to COPD Death
Source: MedPage Today Public Health & Policy [2008.11.25]
BOSTON (MedPage Today) -- Exposure to diesel exhaust is associated with an increased risk of death from chronic obstructive pulmonary disease, a retrospective cohort study of railroad workers showed.
Inhaled Corticosteroids May Heighten Pneumonia Risk in COPD Patients
Source: MedPage Today Pulmonary [2008.11.25]
BALTIMORE (MedPage Today) -- For patients with stable chronic obstructive pulmonary disease, use of inhaled corticosteroids may increase the risk of developing pneumonia, a systematic review showed.
Long-Term Erythromycin Therapy Limits COPD Exacerbations
Source: MedPage Today Pulmonary [2008.11.21]
LONDON (MedPage Today) -- For moderate to severe chronic obstructive pulmonary disease patients, daily treatment with a macrolide antibiotic reduced the rate of exacerbations, a randomized, placebo-controlled trial showed.
Fears Over Asthma Misdiagnosis Lead To British Lung Foundation Calls For Mass Retesting
Source: Allergy News From Medical News Today [2008.11.20]
The British Lung Foundation is calling for everyone over 35 with Asthma or the progressive illness Chronic Obstructive Pulmonary Disease (COPD) to be retested following evidence of confusion over diagnosis and treatment of the two respiratory diseases. A survey of 776 GPs from all over the UK carried out for the charity by Doctors.net.uk shows that most have difficulty differentiating between Asthma or COPD, causing misdiagnosis and distress amongst patients.
Mpex Pharmaceuticals Presents New Data On MP-376 In Cystic Fibrosis
Source: Cystic Fibrosis News From Medical News Today [2008.10.24]
Mpex Pharmaceuticals, Inc. announced additional clinical and preclinical results with MP-376, the company's novel formulation of levofloxacin inhaled solution delivered by an Investigational eFlow Nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Clinical results show that aerosol dosing of MP-376 was well tolerated at all dose levels tested after 14 days of dosing.
|
